• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析中的低钠血症:单中心流行病学及与临床和生化参数的相关性

Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters.

作者信息

Dimitriadis Chrysostomos, Sekercioglu Nigar, Pipili Chrysoula, Oreopoulos Dimitrios, Bargman Joanne M

机构信息

The Home Peritoneal Dialysis Unit, University Health Network and University of Toronto, Toronto, Ontario, Canada.

出版信息

Perit Dial Int. 2014 May;34(3):260-70. doi: 10.3747/pdi.2012.00095. Epub 2013 May 1.

DOI:10.3747/pdi.2012.00095
PMID:23636436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4033326/
Abstract

BACKGROUND

Hyponatremia in peritoneal dialysis (PD) patients has previously been associated with water overload and weight gain, or with malnutrition and intracellular potassium depletion. Although there is a sizable literature about transmembrane sodium and water removal in PD, there are few reports about the incidence and characteristics of hyponatremia in the clinical setting.

AIM

We evaluated the incidence and factors associated with hyponatremia in PD patients in a single PD unit.

METHODS

We retrospectively evaluated the records of all patients (n = 198) who were treated with PD in the Home PD Unit of the University Health Network at Toronto General Hospital during 2010. We identified 166 patients who had a minimum follow-up of 60 days during 2010 and at least 2 consecutive sodium measurements at least a month apart. We examined baseline differences between patients who developed hyponatremia and those who did not, and clinical and biochemical factors that correlated with mean sodium values. In the 24 patients who developed hyponatremia, we examined paired differences between the normonatremic and hyponatremic periods. Finally, we investigated any possible correlations of change in serum sodium with clinical and biochemical characteristics before and during the hyponatremic period.

RESULTS

The incidence of hyponatremia was 14.5%. In multivariate analysis, serum sodium correlated significantly and independently with residual renal function (RRF: r = 0.463, p = 0.0001) and negatively with the daily volume of instilled icodextrin (r = -0.476, p = 0.0001). Residual renal function was significantly lower in patients with hyponatremia than in those with normal serum sodium (1.97 ± 2.3 mL/min vs 4.31 ± 5.01 mL/min, p = 0.033). The mean paired difference in body weight was -1.113 kg and the median difference was -0.55 kg (range: -8.5 kg to +4.2 kg). Impressively, hyponatremia was not associated with an increase in body weight in most patients who developed this complication (13 of 16 for whom comparative weights were known). Moreover, the mean paired change in serum sodium (ΔNa) from normonatremia to hyponatremia was, contrary to our expectations, significantly correlated with a decrease in body weight (r = 0.584, p = 0.017). The ΔNa was also significantly correlated with serum potassium (r = 0.526, p = 0.008), the greatest drop in serum sodium being associated with lower serum potassium in the hyponatremic period, as predicted.

CONCLUSIONS

Hyponatremia is seen more often than expected in a clinical setting. Serum sodium is strongly correlated with RRF, hyponatremia being associated with lower RRF. In patients who experienced hyponatremia, the fall in serum sodium was associated with a decrease, not an increase, in body weight and was correlated with serum potassium, suggesting that sodium and potassium depletion-and, by inference, malnutrition-may be important contributors in the clinical setting.

摘要

背景

腹膜透析(PD)患者的低钠血症此前一直与水负荷过重和体重增加,或与营养不良及细胞内钾缺乏有关。尽管有大量关于PD中跨膜钠和水清除的文献,但关于临床环境中低钠血症的发生率和特征的报道却很少。

目的

我们评估了单一PD治疗单元中PD患者低钠血症的发生率及相关因素。

方法

我们回顾性评估了2010年在多伦多综合医院大学健康网络家庭PD治疗单元接受PD治疗的所有患者(n = 198)的记录。我们确定了166例在2010年至少随访60天且至少相隔一个月进行至少2次连续钠测量的患者。我们检查了发生低钠血症的患者与未发生低钠血症患者之间的基线差异,以及与平均钠值相关的临床和生化因素。在24例发生低钠血症的患者中,我们检查了正常血钠期与低钠血症期之间的配对差异。最后,我们研究了低钠血症期前后血清钠变化与临床和生化特征之间的任何可能相关性。

结果

低钠血症的发生率为14.5%。在多变量分析中,血清钠与残余肾功能显著且独立相关(RRF:r = 0.463,p = 0.0001),与每日注入艾考糊精的量呈负相关(r = -0.476,p = 0.0001)。低钠血症患者的残余肾功能显著低于血钠正常的患者(1.97 ± 2.3 mL/分钟对4.31 ± 5.01 mL/分钟,p = 0.033)。体重的平均配对差异为-1.113 kg,中位数差异为-0.55 kg(范围:-8.5 kg至+4.2 kg)。令人印象深刻的是,在大多数发生这种并发症的患者中(已知比较体重的16例中有13例),低钠血症与体重增加无关。此外,与我们的预期相反,从正常血钠到低钠血症的血清钠平均配对变化(ΔNa)与体重减轻显著相关(r = 0.584,p = 0.017)。ΔNa也与血清钾显著相关(r = 0.526,p = 0.008),如预期的那样,低钠血症期血清钠下降幅度最大与较低的血清钾相关。

结论

在临床环境中,低钠血症的出现比预期更频繁。血清钠与残余肾功能密切相关(RRF),低钠血症与较低的RRF相关。在经历低钠血症的患者中,血清钠的下降与体重减轻而非增加相关,并且与血清钾相关,这表明钠和钾缺乏——以及由此推断的营养不良——可能是临床环境中的重要因素。

相似文献

1
Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters.腹膜透析中的低钠血症:单中心流行病学及与临床和生化参数的相关性
Perit Dial Int. 2014 May;34(3):260-70. doi: 10.3747/pdi.2012.00095. Epub 2013 May 1.
2
Body sodium, potassium and water in peritoneal dialysis-associated hyponatremia.腹膜透析相关性低钠血症中的机体钠、钾和水
Perit Dial Int. 2014 May;34(3):253-9. doi: 10.3747/pdi.2012.00201.
3
Evaluating Hyponatremia in Non-Diabetic Uremic Patients on Peritoneal Dialysis.评估接受腹膜透析的非糖尿病尿毒症患者的低钠血症
Perit Dial Int. 2016 Mar-Apr;36(2):196-204. doi: 10.3747/pdi.2014.00239. Epub 2015 Sep 15.
4
Hyponatremia and hypokalemia in patients on peritoneal dialysis.腹膜透析患者的低钠血症和低钾血症
Semin Dial. 2010 Nov-Dec;23(6):575-80. doi: 10.1111/j.1525-139X.2010.00789.x. Epub 2010 Dec 2.
5
Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis.低钠血症是腹膜透析相关性腹膜炎预后不良的替代标志物。
BMC Nephrol. 2014 Jul 10;15:113. doi: 10.1186/1471-2369-15-113.
6
Characteristics and clinical outcomes of hyponatraemia in peritoneal dialysis patients.腹膜透析患者低钠血症的特征和临床结局。
Nephrology (Carlton). 2013 Feb;18(2):132-7. doi: 10.1111/nep.12013.
7
Hyponatremia and Cognitive Impairment in Patients Treated with Peritoneal Dialysis.接受腹膜透析治疗患者的低钠血症与认知障碍
Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1806-13. doi: 10.2215/CJN.02240215. Epub 2015 Jul 31.
8
Hyponatremia in peritoneal dialysis patients.腹膜透析患者的低钠血症
Clin Nephrol. 2004 Jan;61(1):54-8. doi: 10.5414/cnp61054.
9
Analysis of Factors Influencing the Prognostic Significance of Hyponatremia in Peritoneal Dialysis Patients.分析影响腹膜透析患者低钠血症预后意义的因素。
Am J Nephrol. 2020;51(1):54-64. doi: 10.1159/000504870. Epub 2019 Dec 6.
10
A physiological analysis of hyponatremia: implications for patients on peritoneal dialysis.低钠血症的生理学分析:对腹膜透析患者的影响
Perit Dial Int. 2001 Jan-Feb;21(1):7-13.

引用本文的文献

1
Serum sodium to chloride ratio and mortality on continuous ambulatory peritoneal dialysis: a multicenter retrospective study.持续性非卧床腹膜透析患者的血清钠氯比值与死亡率:一项多中心回顾性研究
MedComm (2020). 2025 Jan 10;6(1):e70041. doi: 10.1002/mco2.70041. eCollection 2025 Jan.
2
[Consensus recommendations on the diagnosis and treatment of hyponatremia from the Austrian Society for Nephrology 2024].[奥地利肾脏病学会2024年低钠血症诊断与治疗共识建议]
Wien Klin Wochenschr. 2024 Feb;136(Suppl 1):1-33. doi: 10.1007/s00508-024-02325-5. Epub 2024 Feb 29.
3
Complications of Peritoneal Dialysis Part II: Nonmechanical Complications.腹膜透析并发症第二部分:非机械性并发症。
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):791-799. doi: 10.2215/CJN.0000000000000418. Epub 2024 Jan 8.
4
Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis.腹膜透析期间因超适应证使用艾考糊精过量导致的中度高渗性低钠血症。
Clin Nephrol Case Stud. 2023 Apr 12;11:61-65. doi: 10.5414/CNCS110854. eCollection 2023.
5
Post-operative dysnatremia is associated with adverse early outcomes after surgery for congenital heart disease.术后电解质紊乱与先天性心脏病手术后的不良早期结局相关。
Pediatr Res. 2023 Aug;94(2):611-617. doi: 10.1038/s41390-023-02495-4. Epub 2023 Jan 27.
6
Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment.慢性肾脏病中的钠代谢紊乱:病理生理学、表现及治疗
Front Med (Lausanne). 2021 Dec 6;8:769287. doi: 10.3389/fmed.2021.769287. eCollection 2021.
7
The Association Between Handgrip Strength and Predialysis Serum Sodium Level in Patients With Chronic Kidney Disease Stage 5D.慢性肾脏病5D期患者握力与透析前血清钠水平之间的关联
Front Med (Lausanne). 2021 Jan 12;7:610659. doi: 10.3389/fmed.2020.610659. eCollection 2020.
8
Prevalence, risk factors and impact on outcomes of 30-day unexpected rehospitalization in incident peritoneal dialysis patients.新诊断腹膜透析患者 30 天内非预期再住院的发生率、风险因素及其对结局的影响。
BMC Nephrol. 2021 Jan 6;22(1):4. doi: 10.1186/s12882-020-02201-0.
9
Possible association between dysnatremias and mortality during hospitalization in patients undergoing acute hemodialysis: analysis from a Peruvian retrospective cohort.急性血液透析患者住院期间血钠异常与死亡率之间的可能关联:一项秘鲁回顾性队列分析
J Bras Nefrol. 2019 Oct-Dec;41(4):501-508. doi: 10.1590/2175-8239-JBN-2018-0243.
10
Hyponatremia in the Dialysis Population.透析人群中的低钠血症
Kidney Int Rep. 2019 Mar 1;4(6):769-780. doi: 10.1016/j.ekir.2019.02.012. eCollection 2019 Jun.

本文引用的文献

1
Mortality associated with low serum sodium concentration in maintenance hemodialysis.维持性血液透析患者低血清钠浓度与死亡率的相关性。
Am J Med. 2011 Jan;124(1):77-84. doi: 10.1016/j.amjmed.2010.07.029.
2
Hyponatremia and hypokalemia in patients on peritoneal dialysis.腹膜透析患者的低钠血症和低钾血症
Semin Dial. 2010 Nov-Dec;23(6):575-80. doi: 10.1111/j.1525-139X.2010.00789.x. Epub 2010 Dec 2.
3
Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.腹膜透析中的钠清除:艾考糊精和腹膜透析方式的作用
Adv Perit Dial. 2008;24:27-31.
4
Blood pressure, volume, and sodium control in an automated peritoneal dialysis population.自动腹膜透析人群的血压、容量及钠控制
Perit Dial Int. 2007 Sep-Oct;27(5):537-43.
5
Hyponatremia in peritoneal dialysis patients.腹膜透析患者的低钠血症
Clin Nephrol. 2004 Jan;61(1):54-8. doi: 10.5414/cnp61054.
6
Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.接受持续性非卧床腹膜透析(CAPD)和自动化腹膜透析的患者的钠清除情况。
Perit Dial Int. 2002 Nov-Dec;22(6):705-13.
7
Metabolic and laboratory effects of icodextrin.
Kidney Int Suppl. 2002 Oct(81):S62-71. doi: 10.1046/j.1523-1755.62.s81.9.x.
8
Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.液体和钠清除对腹膜透析患者死亡率的影响。
Kidney Int. 2001 Aug;60(2):767-76. doi: 10.1046/j.1523-1755.2001.060002767.x.
9
Peritoneal dialysis: new developments and new problems.
Diabet Med. 2001 May;18(5):360-3. doi: 10.1046/j.1464-5491.2001.00455.x.
10
Hyponatremia in patients undergoing CAPD: role of water gain and/or malnutrition.
Perit Dial Int. 2001 Jan-Feb;21(1):72-6.